Skip to main content
Open access
Research Article
20 August 2026

Comparison of a capillary blood collection device and standard venepuncture for routine clinical biochemistry assays: developing reasonable adjustment phlebotomy for patients with learning disabilities

Abstract

Attending a phlebotomy appointment can cause high levels of anxiety, especially in patients with learning disabilities (LD). This project explores the validation of blood tests using capillary blood versus routine venepuncture samples and looks at reducing healthcare inequalities in our local population by providing painless capillary blood testing. Aim: To validate reduced total serum volume required for 23 biochemistry tests, to investigate comparability of results from capillary blood using an upper arm device versus standard venous collection. A secondary aim was to determine the feasibility of capillary blood collection in a community-based population with LD and needle phobia. Materials & methods: Total serum sample volume was reduced until Beckman Coulter AU5800 and DXI800 automated analyzers flagged insufficient sample at a rate of <5% for 23 routine biochemistry tests. Venous and contemporary capillary collections were made from 74 primary care patient volunteers undergoing routine health checks, following informed consent. Comparative statistical analysis (Pearson/Spearman correlation, Bland–Altman) was used to determine interchangeability between the two sets of results. Supervised capillary sampling was then piloted in 20 patients with LD and needle phobia in a community setting. Questionnaires were provided for assessing user acceptability. Results: Total serum volume used for analysis was reduced by up to 30% for some assays. Interchangeability of results was seen with total bilirubin, ALT, ALP, total protein, phosphate, total, LDL and HDL cholesterol, triglycerides, vitamin B12, folate, TSH and prolactin. Further tests, while not completely interchangeable proved useful in longitudinal health monitoring. Conclusion: We have optimized testing capabilities within our laboratory by validating capillary blood for routine testing of commonly requested analytes. Microsamples obtained by capillary access provide a viable alternative to venous phlebotomy in patients with LD and needle phobia.

Plain language summary

This article is about testing to see if blood samples taken from a patient using an upper arm capillary sampling device, gives the same results as a blood sample taken from a traditional venepuncture. Once this was done, we also tested the end to end process of requesting tests, taking a blood sample and returning to the central hospital laboratory for measurement to ensuring accurate results were delivered back to the requesting clinician. We looked at the feasibility of the process in our patient group with learning disabilities and needle phobia, to see how they felt about the capillary blood sampling process and if it was acceptable for them.
We demonstrated that most biochemical tests investigated using capillary blood sampling, gave results that were comparable to those obtained by traditional venepuncture methods. Our learning disabilities patient group and their carers gave us positive feedback on their experience using the capillary sampling device. This means we can offer a basic blood testing alternative for patients who have not been able to access blood tests for routine health checks for years, and sometimes at all. This opens an important new development in breaking down health inequalities in this patient group.

Supplementary Material

File (supplementary materials.pptx)

References

1.
5.
Learning from lives and deaths – people with a learning disability and autistic people (LeDeR). (2021). https://www.kcl.ac.uk/research/leder
6.
Protti M, Mandrioli R, Mercolini L. Tutorial: volumetric absorptive microsampling (VAMS). Analytica Chimica Acta 1046, 32–47 (2019).
7.
Marshall DJ, Kim JJ, Brand S, Bryne C, Keevil BG. Assessment of tacrolimus and creatinine concentration collected using Mitra microsampling devices. Ann. Clin. Biochem. 57(5), 389–396 (2020).
8.
Lattin MT et al. Painless needle-free capillary blood collection for fertility hormone monitoring. Fertil. Steril. 124(5 Pt 2), 1124–1126 (2025).
9.
Zarbi J, Eimer E, Gigg C et al. Remote self-collection of capillary blood using upper arm devices for autoantibody analysis in patients with immune-mediated inflammatory rheumatic diseases. Rheumatic Skeletal Dis. 8, e002641 (2022).
10.
Voigt KR, Wullaert L, Verhoef C, Grunhagen DJ, Ramakers C. Reliable capillary sampling of carcinoembryonic antigen at home: CASA feasibility study. Colorectal Dis. 25, 1163–1168 (2023).
11.
Collier BB, Brandon WC, Chappell MR, Kovach PM, Grant RP. Maximising microsampling: measurement of comprehensive metabolic and lipid panels using a novel capillary blood collection device. J. Appl. Lab. Med. 8(6), 1115–1126 (2023).
12.
Silliman E, Chung EH, Fitzpatrick E et al. Evaluation of at-home serum anti-mullerian hormone testing: a head-to-head comparison study. Reprod. Biol. Endocrinol. 20, 113 (2022).
13.
Besser REJ, Long AE, Owen KR et al. Transdermal sampling for c-peptide is a minimally invasive, reliable alternative to venous sampling in children and adults with type 1 diabetes. Diabetes Care 47, 239–245 (2024).
14.
EP15-A3. User Verification of Precision and Estimation of bias, Approved Guideline – (3rd Edition). Clinical and Laboratory Standards Institute (2014).
15.
McCormack JP, Holmes DT. Your results may vary: the imprecision of medical measurements. Br. Med. J. 368, 1–5 (2020).
16.
Aarsand A, Fernandez-Calle P, Webster C et al. The EFLM biological variation database. (2022). https://biologicalvariation.eu/
17.
Nwankwo L, McLaren K, Donovan J et al. Utilisation of remote capillary blood testing in an outpatient clinic setting to improve shared decision making and patient and clinical experience: a validation and pilot study. BMJ Open Qual. 10, e001192 (2021).
18.
Ansari S, Abdel-Malek M, Kenkre J et al. The use of whole blood capillary samples to measure 15 analytes for a home-collect biochemistry service during the SARS-CoV-2 pandemic: a proposed model form North West London Pathology. Ann. Clin. Biochem. 58(5), 411–421 (2021).
19.
Thue G, Sandberg S. Analytical performance specifications based on how clinicians use laboratory tests. Experiences from a post-analytical external quality assessment programme. Clin. Chem. Lab Med. 53(6), 857–862 (2015).
20.
CLSI. Evaluation of detection caPAbility for clinical laboratory measurement procedures. 2nd Ed. CLSI document EP 17-A2. Clinical and Laboratory Standards Institute, PA, USA (2012).
21.
DiPasquale C, Christenson RH, Donnelly JG et al. Equivalence between capillary blood and venous blood test results using miniaturised assays and novel collection methods to support routine blood work. J. Appl. Lab. Med. 10(5), 1090–1140 (2025).
22.
Hosseini B, Dasari H, Smyrnova A et al. Concordance in COVID-19 serology, bone mineralization and inflammatory analytes between venous and self-collected capillary blood samples exposed to various pre-analytical conditions. Ann. Clin. Biochem. Int. J. Lab. Med. 60(4), 259–269 (2023).
23.
Wickremsinhe E, Fanatana A, Berthier E et al. Standard venipuncture vs a capillary blood collection device for the prospective determination of abnormal liver chemistry. J. Appl. Lab. Med. 8(3), 535–550 (2023).
24.
Marshall DJ, Kim JJ, Brand S, Bryne C, Keevil BG. Assessment of tacrolimus and creatinine concentration collected using Mitra microsampling devices. Ann. Clin. Biochem. 57(5), 389–396 (2020).
25.
Spooner N, Baker D, Carling RS et al. Patient centric blood sampling and analysis for diagnostics and laboratory medicine. Bioanalysis 17, 20 (2025).
26.
Woolley T, Hepburn S, Perkins K. Automatic for the people: an introduction to self-collected capillary blood testing. J.Patient Centricity. (2026). https://doi.org/10.57264/jpc-2026-0002
27.
Heslop P, Blair P, Flemming P et al. Confidential inquiry into premature deaths of people with learning disabilities (CIPOLD). (2013). (Accessed 4 April 2024). https://www.hqip.org.uk/resource/confidential-enquiry-into-deaths-of-people-with-learning-disabilities-cipold-2013/
28.
Boarden R, Harvey G, Moxham C, Proudlove N. NHS Institute for Innovation and Improvement, Coventry House, University of Warwick Campus, Coventry, CV4 7AL. Quality improvement: theory and practice in Healthcare. NHS Institute for Innovation and Improvement. (2008).
29.
Malik R, Giles C. Supporting people with learning disabilities to have blood tests. Learning Disability Practice 23(1), 18–25 (2020).
30.
NHS England CORE20PLUS5 (adults) – an approach to reducing healthcare inequalities. (Accessed December 2023). https://www.england.nhs.uk/about/equality/equality-hub/national-healthcare-inequalities-improvement-programme/core20plus5/ .
31.
Jarvis S. PatientInfo.com. Overcoming a fear of needles (needle phobia) (2019). https://patient.info/features/mental-health/overcoming-your-fear-of-needles